Acta Materia Medica (Aug 2022)

Establishment of a protein thermal shift chip (PTSC) for COVID-19 and exploration of the future of protein chips in pharmacology

  • Peng Chen,
  • Zhao Cui,
  • Caifeng Li,
  • Shiwen Deng,
  • Hongjun Yang

DOI
https://doi.org/10.15212/AMM-2022-0016
Journal volume & issue
Vol. 1, no. 3
pp. 314 – 319

Abstract

Read online

Traditional protein chips are based on solid chips and cannot enable drug and target screening in a label-free manner. Herein, a protein thermal shift chip (PTSC) based on fluorescence signals is proposed, which enables low-cost, high-throughput, label-free screening. We developed a PTSC for COVID-19, containing 12 SARS-CoV-2 and host target proteins. A series of quality-control tests were performed for small-molecule drugs, macromolecular antibodies, and herbal-medicine extracts. This chip enabled high-throughput screening of COVID-19 drugs and thus may serve as a tool for screening drug targets clinically effective drugs.

Keywords